Healthcare Roundup – Pfizer runs early on schedule to supply 200M COVID vaccine doses to U.S. by May; Cassava surges after favorable trial data for simufilam in Alzheimer’s diseaseLife Science
Healthcare Roundup – Illumina surges after patent win; announces collaboration in China; BioCryst climbs after being named ‘the most undervalued stock in the marketLife Science
Healthcare Roundup – AstraZeneca gets European nod for COVID-19 vaccine; eHealth announces $225M strategic investment from H.I.G. capitalLife Science
Healthcare Roundup – AstraZeneca COVID-19 shot is only for those aged 18-64 in Germany, Hims & Hers Health soars after Cathie Wood’s ETF discloses stakeLife Science
Healthcare Roundup – Pfizer’s setback can hurt others with JAK inhibitors, EyePoint surges after Cantor Fitzgerald nod; potential of EYP-1901 citedLife Science
Healthcare Roundup – Lilly bamlanivimab combo therapy lowers COVID-19 hospitalizations, JNJ earnings release brightens U.S. biopharma outlookLife Science
Healthcare Roundup- Merck discontinues development of V590 and V591 COVID-19 vaccine candidates, Moderna’s COVID-19 jab retains neutralizing activity against emerging virus variantsLife Science
Healthcare Roundup – Intuitive Surgical earns mixed reviews from analysts despite earnings beat; Amyris acquires Terasana Brand for offering clean cannabinoid consumer productsLife Science
Healthcare Roundup – Moderna says dosing underway in Takeda-led early-stage COVID vaccine trial in Japan; Gene editors raise equity as shares climb amid investor interestLife Science
Healthcare Roundup – Adamis Pharma soars on Tempol IND submission for COVID-19 treatment; MindMed kicks off early stage trial for LSD-MDMA cocktailLife Science
Healthcare Roundup – Moderna drops as company acknowledges allergic reactions to COVID-19 shot, Eli Lilly upgraded to buy at Mizuho on positive donanemab dataLife Science
Healthcare Roundup – COVID-19 Jabs: Israel trades data for doses; U.K. to vaccinate all adults by September；Grifols to trial new immunoglobulin therapy against COVID-19Life Science
Healthcare Roundup – Norway says deaths after COVID-19 jab may be from side effects, Sorrento could nearly quadruple in value: analystLife Science
Healthcare Roundup – The world will have to live with COVID forever; Gilead attributes long term growth to oncology franchise, excludes remdesivirLife Science
Healthcare Roundup – JNJ’s COVID-19 vaccine data published in Medical Journal, Evolus is up 6% after AbbVie-Cypris Medical dealLife Science
